Nov 1, 2024, 11:28
Sherene Loi: Long-Term affects of Adjuvant Breast Cancer Treatment on Lymphocyte Counts
Sherene Loi, Medical Oncologist, Lab Head of Breast Oncology Clinical Trials at Peter MacCallum Cancer Centre, shared on X:
“Sharing our latest article: Here we show that dose dense AC-T, radiotherapy and age affects long-term lymphocyte counts post adjuvant breast cancer treatment ?implications for IO therapy.”
Sustained lymphocyte decreases after treatment for early breast cancer
Authors: Julia Dixon-Douglas, Balaji Virassamy, Kylie Clarke, Michael Hun, Stephen J. Luen, Peter Savas, Courtney T. van Geelen, Steven David, Prudence A. Francis, Roberto Salgado, Stefan Michiels, Sherene Loi
More posts featuring Immunotherapy on oncodaily.com
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Dec 2, 2024, 22:51
Dec 2, 2024, 22:47
Dec 2, 2024, 22:38
Dec 2, 2024, 22:36
Dec 2, 2024, 21:38
Dec 2, 2024, 20:23